Sergio
Vaño Galván
Profesor/a Asociado/a en CC. de la Salud


New York University School of Medicine
Nueva York, Estados UnidosPublications in collaboration with researchers from New York University School of Medicine (17)
2024
-
The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results from a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity
JAMA Dermatology, Vol. 160, Núm. 3, pp. 341-350
2021
-
5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia
Journal of the European Academy of Dermatology and Venereology
-
A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)
JAMA Dermatology, Vol. 157, Núm. 4, pp. 439-448
-
Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients
Journal of the European Academy of Dermatology and Venereology
-
Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
Medical Hypotheses, Vol. 146
-
Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men
Journal of the European Academy of Dermatology and Venereology
-
Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)*
British Journal of Dermatology, Vol. 185, Núm. 6, pp. 1221-1231
-
Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
Frontiers in Medicine, Vol. 8
-
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
Journal of the American Academy of Dermatology, Vol. 84, Núm. 6, pp. 1644-1651
-
Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management
JAAD International, Vol. 5, pp. 11-18
2020
-
A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain – A potential clue to the role of androgens in COVID-19 severity
Journal of Cosmetic Dermatology
-
Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
Journal of the American Academy of Dermatology, Vol. 83, Núm. 2, pp. 680-682
-
Clock genes may drive seasonal variation in sars-cov-2 infectivity: Are we due for a second wave of covid-19 in the fall?
Journal of Biological Regulators and Homeostatic Agents
-
Novel topical booster enhances follicular sulfotransferase activity in patients with androgenetic alopecia: a new strategy to improve minoxidil response
Journal of the European Academy of Dermatology and Venereology
-
Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?
Journal of Cosmetic Dermatology
-
What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy
Dermatologic Therapy
2019
-
Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study
Skin Appendage Disorders, Vol. 5, Núm. 5, pp. 309-315